Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Eur J Neurol ; 26(7): 979-985, 2019 07.
Artículo en Inglés | MEDLINE | ID: mdl-30706593

RESUMEN

BACKGROUND AND PURPOSE: The prevalence and duration of non-motor symptoms (NMS) in prodromal Parkinson's disease (PD) has not been extensively studied. The aim of this study was to determine the prevalence and duration of prodromal NMS (pNMS) in a cohort of patients with recently diagnosed PD. METHODS: We evaluated the prevalence and duration of pNMS in patients with early PD (n = 154). NMS were screened for using the Non-Motor Symptom Questionnaire (NMSQuest). We subtracted the duration of the presence of each individual NMS reported from the duration of the earliest motor symptom. NMS whose duration preceded the duration of motor symptoms were considered a pNMS. Individual pNMS were then grouped into relevant pNMS clusters based on the NMSQuest domains. Motor subtypes were defined as tremor dominant, postural instability gait difficulty (PIGD) and indeterminate type according to the Movement Disorder Society Unified Parkinson's Disease Rating Scale revision. RESULTS: Prodromal NMS were experienced by 90.3% of patients with PD and the median number experienced was 4 (interquartile range, 2-7). A gender difference existed in the pNMS experienced, with males reporting more sexual dysfunction, forgetfulness and dream re-enactment, whereas females reported more unexplained weight change and anxiety. There was a significant association between any prodromal gastrointestinal symptoms [odds ratio (OR), 2.30; 95% confidence interval (CI), 1.08-4.89, P = 0.03] and urinary symptoms (OR, 2.54; 95% CI, 1.19-5.35, P = 0.016) and the PIGD phenotype. Further analysis revealed that total pNMS were not significantly associated with the PIGD phenotype (OR, 1.10; 95% CI, 0.99-1.21, P = 0.068). CONCLUSIONS: Prodromal NMS are common and a gender difference in pNMS experienced in prodromal PD may exist. The PIGD phenotype had a higher prevalence of prodromal gastrointestinal and urinary tract symptoms.


Asunto(s)
Ansiedad/epidemiología , Enfermedad de Parkinson/diagnóstico , Disfunciones Sexuales Fisiológicas/epidemiología , Temblor/diagnóstico , Anciano , Ansiedad/diagnóstico , Ansiedad/fisiopatología , Femenino , Marcha/fisiología , Humanos , Masculino , Persona de Mediana Edad , Enfermedad de Parkinson/fisiopatología , Prevalencia , Síntomas Prodrómicos , Disfunciones Sexuales Fisiológicas/diagnóstico , Disfunciones Sexuales Fisiológicas/fisiopatología , Encuestas y Cuestionarios , Temblor/fisiopatología
2.
J R Coll Physicians Edinb ; 46(3): 160-162, 2016 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-27959349

RESUMEN

Nitrous oxide is commonly used as an analgesic and anaesthetic agent. Nitrous oxide is also in use in industry as an aerosol propellant and is now recognised as a recreational drug whose use is growing, especially among the young. Nitrous oxide from whipped cream canisters is inhaled to produce a dissociative, intoxicated state. Nitrous oxide is known to inactivate vitamin B12 via oxidation, which can precipitate a demyelinating myelopathy akin to the classical B12 deficiency syndrome, subacute combined degeneration of the spinal cord. This case describes a young woman with chronic pain and a poor nutritional state who took regular nitrous oxide as an opiate-sparing agent. She developed a progressive subacute myelopathy with a sensory level, profoundly impaired joint position sense, extensor plantars and required a wheelchair. Once diagnosed, she responded well to a regime of nitrous oxide withdrawal, high-dose B12 replacement and physiotherapy. The case illustrates the need for clinical teams to be able to dentify a nitrous oxide-precipitated myelopathy as its use as a drug of abuse increases; particularly in the case of malnourished patients who receive nitrous oxide surgically or obstetrically.


Asunto(s)
Accidentes por Caídas , Analgésicos no Narcóticos/efectos adversos , Dolor Crónico/tratamiento farmacológico , Enfermedades Desmielinizantes/inducido químicamente , Óxido Nitroso/efectos adversos , Enfermedades de la Médula Espinal/inducido químicamente , Vitamina B 12/metabolismo , Adulto , Analgésicos no Narcóticos/uso terapéutico , Anestésicos por Inhalación/efectos adversos , Anestésicos por Inhalación/uso terapéutico , Enfermedades Desmielinizantes/complicaciones , Enfermedades Desmielinizantes/metabolismo , Femenino , Humanos , Óxido Nitroso/uso terapéutico , Manejo del Dolor/efectos adversos , Enfermedades de la Médula Espinal/complicaciones , Enfermedades de la Médula Espinal/metabolismo , Deficiencia de Vitamina B 12
3.
J R Coll Physicians Edinb ; 46(3): 182-186, 2016 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-27959355

RESUMEN

Research can be a difficult area for the novice to break into. A number of different obstacles face the new researcher, starting with selecting a suitable supervisor, writing a workable protocol and obtaining permissions from all the relevant organisations. This beginner's guide walks the fledging researcher through the required steps, including formulating a research question, designing a protocol and completing the Integrated Research Application System form to obtain the required permissions. The aim is to demystify the terms used in research and expose some of the pitfalls the authors experienced so that others can avoid them! Although challenges can arise throughout the research process, we aim to help you get underway.


Asunto(s)
Proyectos de Investigación , Investigadores , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...